Celares


Biosynth is an innovative life sciences reagents, custom synthesis, and manufacturing services company dedicated to supplying critical raw materials and services to the pharmaceutical, vaccine, and diagnostic industries. With a focus on complex chemicals, peptides, and biologics, Biosynth aims to de-risk supply chains, improve product availability, and reduce time-to-market for new therapies and diagnostics. The company operates globally with facilities across three continents, offering a vast product portfolio and end-to-end manufacturing services to support research, development, and commercial production.

Industries

biotechnology
pharmaceutical

Nr. of Employees

small (1-50)

Celares

Biosynth Limited, 4-9 Old Station Business Park, Compton, Berkshire, RG20 6NE, United Kingdom


Products

Research reagents catalog (carbohydrates, nucleosides, enzyme substrates, natural products)

Extensive catalog of research chemicals and biochemical reagents across multiple categories and pack sizes for life-science research, assay development and screening.

Peptide products and custom peptide services

Custom and catalog peptides including labeled, modified, constrained and GMP-grade peptides supplied from mg to multikilogram scale, with options for salt exchange, cyclization, conjugation and isotopic labelling.

IVD raw materials (antigens, antibodies, plasma)

Catalog and custom antigens, antibodies and disease-state plasma for in vitro diagnostics, including reagents for emerging pathogens and clinical controls.


Services

Route design, scouting, optimization, analytical development and transfer to manufacture for APIs, intermediates and specialty chemicals, with finishing, packaging and regulatory documentation support.

Discovery services including constrained-peptide screening, peptide design and optimization, analytical support and GMP-grade peptide manufacturing from mg to multikilogram scale; online quoting and order-tracking available.

Design and manufacture of bioconjugates and conjugate vaccines, PEGylated biomolecules and related polymer chemistries, supporting preclinical and clinical production with analytical characterization and GMP options.

Polyclonal and monoclonal antibody generation, antigen design, screening (ELISA/hybridoma screening) and peptide-array epitope mapping services to support assay and therapeutic projects.

Custom enzyme engineering, strain and bioprocess development, fermentation, downstream purification and routine enzyme manufacturing for biocatalysis and diagnostic applications.

Method development, HPLC and mass-spectrometry-based QC, NMR, IC and elemental analysis, amino-acid composition analysis, bioassays and stability testing; HPLC method validation and validation packages available.

View All Services

Expertise Areas

  • Complex chemical CDMO services
  • Peptide discovery, synthesis and GMP peptide manufacturing
  • Bioconjugation process development and manufacturing
  • Recombinant protein expression for diagnostics
  • Show More (6)

Key Technologies

  • Solid-phase peptide synthesis (SPPS)
  • Phage-display constrained-peptide screening
  • Biocatalysis and enzyme engineering
  • Bioconjugation chemistries (including PEGylation and carrier conjugation)
  • Show More (7)

News & Updates

Opening of new Bioconjugation suite in Berlin, Germany.

View the status of all WEB orders from the past six months.

Focus on Customer Experience and Continuous Improvement.

Leadership appointment to strengthen the Life Sciences division.

Recognition for sustainability efforts at Staad and Dublin sites.

Exploration of suicide substrates and their application in clinical bacteria enrichment.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.